Share on StockTwits

Equities researchers at Topeka Capital Markets hoisted their target price on shares of Medidata Solutions (NASDAQ:MDSO) to $49.00 in a research report issued on Wednesday. Topeka Capital Markets’ price target suggests a potential upside of 19.03% from the stock’s previous close.

MDSO has been the subject of a number of other recent research reports. Analysts at Stifel initiated coverage on shares of Medidata Solutions in a research note on Tuesday. They set a “buy” rating and a $47.00 price target on the stock. Separately, analysts at Stifel Nicolaus initiated coverage on shares of Medidata Solutions in a research note on Tuesday. They set a “buy” rating and a $47.00 price target on the stock. Finally, analysts at Ned Davis Research upgraded shares of Medidata Solutions from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $56.57.

Medidata Solutions (NASDAQ:MDSO) opened at 41.165 on Wednesday. Medidata Solutions has a 1-year low of $32.10 and a 1-year high of $68.21. The stock has a 50-day moving average of $37.73 and a 200-day moving average of $52.90. The company has a market cap of $2.152 billion and a P/E ratio of 226.86.

Medidata Solutions (NASDAQ:MDSO) last released its earnings data on Tuesday, April 22nd. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by $0.05. The company had revenue of $76.60 million for the quarter, compared to the consensus estimate of $79.50 million. During the same quarter in the previous year, the company posted $0.18 earnings per share. The company’s revenue for the quarter was up 21.0% on a year-over-year basis. Analysts expect that Medidata Solutions will post $0.75 EPS for the current fiscal year.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.